Form D · Other Health Care
Truepill, Inc.
Hayward, CA · CIK 0001796680
Offering snapshot reported Sep 1, 2023 · SEC filing
- Reported sold
- $66.2M Offering amount: $107M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 16, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 1, 2023 | Initial | $66,179,603 | No comparison | 14 | SEC filing |
| Oct 29, 2021 | Initial | $142,476,323 | No comparison | 9 | SEC filing |
| Sep 10, 2020 | Initial | $75,539,719 | No comparison | 10 | SEC filing |
| Dec 17, 2019 | Initial | $23,296,309 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-491244
Source: Form D, filed Sep 1, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mohammad Umar Afridi | Director, Executive |
| Alex Bangash | Director |
| Paul Greenall | Director, Executive |
| Annie Lamont | Director |
| Ann Lamont | Director |
| John M. Prince | Director |
| Larry Renfro | Director |
| Daniel Simkin | Executive |
| Garry Tan | Director |
| Siddarth Viswanathan | Director, Executive |
| Eric Woersching | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
3121 Diablo Ave
Hayward, CA, 94545
Hayward, CA, 94545